Drug Shortage Report for TEVA-CLOBETASOL

Last updated on 2022-02-05 History
Report ID 141457
Drug Identification Number 01910272
Brand name TEVA-CLOBETASOL
Common or Proper name CLOBETASOL 0.05% CREAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLOBETASOL PROPIONATE
Strength(s) 0.05%
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging size 15g & 50g
ATC code D07AD
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-06-23
Estimated end date 2022-01-31
Actual end date 2022-02-04
Shortage status Resolved
Updated date 2022-02-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-06-24 English Compare
v2 2021-06-24 French Compare
v3 2021-07-08 English Compare
v4 2021-07-08 French Compare
v5 2021-07-15 English Compare
v6 2021-07-15 French Compare
v7 2021-08-05 English Compare
v8 2021-08-05 French Compare
v9 2021-08-27 English Compare
v10 2021-08-27 French Compare
v11 2021-09-02 English Compare
v12 2021-09-02 French Compare
v13 2021-11-04 English Compare
v14 2021-11-04 French Compare
v15 2021-11-25 English Compare
v16 2021-11-25 French Compare
v17 2021-12-22 English Compare
v18 2021-12-22 French Compare
v19 2022-02-04 English Compare
v20 2022-02-04 French Compare

Showing 1 to 20 of 21